ABSTRACT
Although anti-thrombotic therapy has been successful for prevention of deaths from acute myocardial infarction (MI), by far, there are few preventive and therapeutic options for ischemic heart failure (IHF) after MI. Qi-Tai-Suan (QTS) is an oleanolic acid (OA) derivative which once underwent a clinical trial for treating hepatitis. In this study, we investigated the potential cardioprotective effect of QTS on IHF. IHF mouse model was constructed by coronary artery ligation in male C57BL/6J mice, and the protective effects of QTS on IHF were examined by echocardiography measurement, histological and TUNEL analysis, etc. We found that QTS exhibited promising cardioprotective effect on IHF. QTS treatment significantly improved cardiac function of IHF mice and the symptoms of heart failure. Notably, QTS had much better oral bioavailability (F = 41.91%) in mice than its parent drug OA, and took effects mainly as its original form. Mechanistically, QTS ameliorated ischemic heart failure likely through suppression of cardiac apoptosis, inflammation and fibrosis. Taken together, QTS holds great promise as a preventive and therapeutic agent for ischemic heart failure and related diseases.
Subject(s)
Animals , Male , Mice , Apoptosis , Fibrosis , Heart Failure/drug therapy , Inflammation/drug therapy , Mice, Inbred C57BL , Myocardial Ischemia/pathology , Oleanolic Acid/pharmacologyABSTRACT
Objective:To discuss clinical effect of Shexiang Tongxin pills to syndrome of Qi deficiency and blood stasis in ischemic heart failure （IHF） and to study the mechanism to myocardial fibrosis and vascular regeneration. Method:One hundred and forty patients were randomly divided into observation group （70 cases） and control group （70 cases） with the same cases. 66 patients in control group finish the therapy （3 patients fall off or lost visit， 1 were eliminated）. 65 patients in observation group completed the therapy （4 patients were falling off， 1 were eliminated）. Both groups patients got combined treatment according to the guiding. Patients in control group got simulated medicine of Shexiang Tongxin pills， 2 pills/time， 3 times/day. Patients in observation group got Shexiang Tongxin pills， 2 pills/time， 3 times/day. The treatment was continued for 24 weeks. Before and after treatment， the left ventricular ejection fraction （LVEF）， cardiac output （CO）， end diastolic diameter （LVEDd）， left posterior wall thickness （LVPW）， left ventricular mass index （LVMI） and left ventricular remodeling index （LVRI） were measured by echocardiography. And scores of six minute walking test （6 MWT）， Lee's heart failure score， Qi deficiency and blood stasis syndrome score and Minnesota Heart Failure Quality of life questionnaire （MLHFQ） were graded. And levels of N-terminal B-type natriuretic peptide （NT-proBNP）， transforming growth factor-β1 （TGF-β1）， soluble ST2 （sST2）， matrix metalloproteinase-2 （MMP-2）， matrix metalloproteinase inhibitor-2 （TIMP-2）， insulin-like growth factor-1 （IGF-1）， vascular endothelial growth factor （VEGF）， angiopoietin1 （Ang1） and angiopoietin2 （Ang2）， and the safety was evaluated. Result:The total clinical effect in observation group was 90.77% （59/65） higher than 74.24% （49/66） in control group （χ2=6.179， P<0.05）. Levels of LVEF， CO， LVRI， 6 MWT， TIMP-2， IGF-1， VEGF and Ang1 were higher than those in control group （P<0.01）. And levels of LVEDd， LVPW and LVMI were lower than those in control group （P<0.05）， levels of NT-proBNP， TGF-β1， sST2， MMP-2 and Ang2 were lower than those in control group （P<0.01）， scores of Lee's heart failure score， Qi deficiency and blood stasis syndrome score and MLHFQ were lower than those in control group （P<0.01）. Besides， there was no adverse reactions caused by Shexiang Tongxin dropping pills. Conclusion:On the basis of conventional western medicine treatment， Shexiang Tongxin drop pills can improve the ventricular remodeling， improve the heart function， reduce the clinical symptoms， increase the exercise tolerance and quality of life of the patients by affecting the myocardial fibrosis and vascular regeneration factor， which has better clinical efficacy and safety.
ABSTRACT
@#Objective To explore the predictive value of myocardial vitality in the improvement of cardiac function after coronary artery bypass grafting (CABG) in patients with ischemic heart failure. Methods From December 8, 2015 to November 12, 2018, 46 patients with ischemic heart failure who underwent CABG operation alone were collected retrospectively. There were 41 males and 5 females with an average age of 60.4±8.0 years. The myocardial vitality and number of different types of myocardium were measured. The clinical data of patients in the left ventricular ejection fraction (LVEF) improvement group (≥5%) and non-improvement group (<5%) were compared and analyzed. The correlation between each index and LVEF improvement was analyzed by logistic multivariate regression analysis, and the boundary value of hibernating myocardium between LVEF improvement and non-improvement was obtained by receiver operating characteristic (ROC) curve. Results There were significant differences in the number of hibernating myocardium (15.0%±12.3% vs. 4.3%±4.5%, P=0.000), the number of normal myocardium (74.7%±13.7% vs. 82.4%±8.6%, P=0.027), and cardiac function classification (NYHA) development (−0.7±0.7 vs. −0.3±0.5, P=0.047) between the two groups, but there was no significant difference in other indexes between the two groups (P>0.05). Logistic regression analysis showed that the number of hibernating myocardium was an independent factor affecting the improvement of LVEF after CABG in patients with ischemic heart failure (OR=1.366, 95%CI 1.033-1.807, P=0.029). The ROC curve showed that the threshold value, sensitivity and specificity of hibernating myocardium were 15.0%, 43.8% and 100.0%, respectively. Conclusion The percentage of hibernating myocardium to left ventricular wall area ≥15.0% can accurately predict the improvement of LVEF in patients with ischemic heart failure after CABG. Preoperative myocardial vitality assessment has important diagnostic value in predicting the improvement of cardiac function in patients with ischemic heart failure after simple CABG.
ABSTRACT
Objective To evaluate the safety and efficacy of epicardial ventricular restoration (EVR) using REVIVENT system in patients with antero-septal scar and dilated ischemic cardiomyopathy. Methods Ten ischemic heart patients with antero-septal scar underwent the operation. The scarred lateral left ventricular wall was apposed to the septal scar with serial paired anchors placed through epicardial transmural excluding the non-viable portions of the chamber. Left ventricular hemodynamic assessments as well as left ventricular ejection fraction, left ventricular end-systolic/diastolic volume (LVEDV/LVESV) and their indexes (LVEDVI/LVESVI) were measured by cardiac magnetic resonance (CMR). Results Ten ischemic heart failure patients with antero-septal scar, aged(55.2±13.9)years, received a hybrid epicardial ventricular restoration. Cardiac MR done at one a month after the procedure showed an elevation of LVEF from(27.8±4.6%)to(37.5±11.4)% (+35%, P<0.01). LVESV was significantly reduced from(149.9±61.6) ml to(109.9±58.0)ml (–26.7%, P<0.01), LVESVI was reduced from(84.8±36.7)ml/m2to(63.0±34.2) ml/m2(reduced by 25.7%, P<0.01); LVEDV was reduced from(203.0±64.0)ml to(167.9±58.2)ml (reduced by 17.3%, P<0.01), and LVESV was reduced from(114.5±37.8)ml/m2to(96.2±35.2)ml/m2(reduced by 16.0%, P<0.01). Cardiac output (CO) increased from(4.0±1.5)L/min to(4.8±1.2)L/min(increased by 20.0%, P=0.034) and cardiac index (CI) increased from(2.2±0.7)L/(min ? m2) to(2.7±0.7)L/(min ? m2) (increased by 22.4%, P=0.023). Conclusions Our preliminary experience on EVR using the REVIVENT system demonstrated signifi cant increase in LVEF, CO and CI, with decreases in LVEDV/LVESV at 1 month following the procedure. Its feasibility and safety need further evaluation in the future.
ABSTRACT
Objective To study the curative effect of enhanced external counterpulsation(EECP) on the ischemic symptoms,heart function and heart failure markers in the patients with ischemic heart failure.Methods One hundred and eithty patients with ischemic heart failure were divided into the external counterpulsation group and the control group.The treatment group received the EECP therapy.The angina curative effect and heart function(ultrasonic echocardiography,noninvasive hemodynamic monitoring,NYHA heart function grade) as well as heart failure markers changes after treatment were observed in the two groups.Results The effective rate of angina treatment in the counterpulsation group was higher than that in the control group,the difference was statistically significant (P＜0.01).The cardiac output (CO) and cardiac index (CI) in the counterpulsation group were significantly higher than those in the control group,the difference was statistically significant (P＜0.01);the stroke volume (SV),stroke volume index (SI),acceleration index (ACI) and velocity index (Ⅵ) in the counterpulsation group were higher than those in the control group,the difference was statistically significant (P＜0.05);the systemic circulation peripheral vascular resistance (SVR),systemic circulation peripheral vascular resistance index (SVRI) and systolic time rate (STR) in the counterpulsation group were lower than those in the control group,the difference was statistically significant (P＜0.05).There were no statistical difference between the two groups in left ventricular ejection fraction(EF),left ventricular end diastolic diameter(LVEDd) and thoracic cavity fluid volume(TFC) (P＞0.05);there was no statistical difference in NYHA heart function grade between the two groups before treatment.The NYHA heart function grade after treatment in the counterpulsation group was improved compared with that in the control group (P＜0.05).There was no statistical difference in NT-proBNP before treatment between the two groups.The NT-proBNP level after treatment in the counterpulsation group was significantly lower than that in the control group,the difference was statistically sinificant(P＜0.01).Conclusion External counterpulsation can be used for the treatment in the patients with ischemic heart failure,can alleviate the angina symptoms,improves the heart function and heart failure markers.
ABSTRACT
Objective To investigate the effects of levosimendan on percutaneous coronary intervention ( PCI) in patients with ischemic heart failure. Methods From January 2013 to June 2016,eighty patients with ischemic heart failure undergoing coronary intervention in Pingdingshan People′s Hospital No. 1 were randomly divided into treatment group ( 40 cases) and control group ( 40 cases) . The treatment group was treated with levosimendan on the basis of routine medicine 2 days before operation,and the control group was given routine medication before operation. The baseline clinical data, operative success rate, complications, left ventricular ejection fraction ( LVEF%) after 1 month, 6 min walking distance, plasma brain natriuretic peptide ( BNP ) , creatinine and other cardiac and renal functions were observed and compared between the two groups. Results The differences of the baseline clinical characteristics including age (65. 5±3. 9 vs. 63. 9±3. 6),male (26 cases (65. 0%) vs. 23 cases (57. 5%) ),hypertension (21 cases (52. 5%) vs. 19 cases (47. 5%) ),diabetes (17 cases ( 42. 5%) vs. 14 cases ( 35. 0%) ) , hyperlipidaemia ( 30 cases ( 75. 0%) vs. 29 cases ( 72. 5%) ) , smoking (21 cases (52. 5%) vs. 19 cases (47. 5%) ),COPD (7 cases (17. 5%) vs. 6 cases (15. 0)%), LDL?C ( (4. 5±1. 0) mmol/L vs. (4. 4±1. 1) mmol/L),BMI ( (25. 9±3. 3) vs. (25. 6±3. 5) ) were not significant (t/χ2=1. 30,0. 47,0. 20,0. 47,0. 07,0. 20,0. 09,0. 49,0. 39,P=0. 20,0. 49,0. 66,0. 49,0. 80, 0. 66,0. 76, 0. 63, 0. 70 ) . There was no significant difference in coronary artery lesion between two groups, including single vessel lesion (11 cases (27. 5%) vs. 15 cases (37. 5%) ),double vessel lesion ( (22 cases ( 55. 0%) vs. 19 cases ( 47. 5%) ) ,three vessel lesion ( ( 7 cases ( 17. 5%) vs. 6 cases ( 15. 0%) ) and left main coronary artery disease (7 cases (17. 5%) vs. 6 cases (15. 0%) ) (Z=-0. 88,P=0. 38). The time of percutaneous coronary intervention ( ( 51. 0±8. 6) min vs. (49. 6 ±9. 6) min),the time of X?ray exposure ( (20. 3±7. 0) min vs. (18. 4±5. 6) min),material consumption ( (123. 2±16. 6) ml vs. (117. 3±25. 1) ml) between two groups have no difference ( t/χ2=0. 70,1. 39,1. 24,P=0. 49,0. 17,0. 22) . There were significant differences between the two groups in the success rate of operation ( 38 cases ( 95. 0%) vs. 31cases ( 77. 5%) , heart failure ( 1 cases ( 2. 5%) vs. 6cases ( 15. 0%) ) and complications ( 2 cases ( 5. 0%) vs. 11 cases (27. 5%) ) (χ2=5. 17,3. 91,7. 44,P=0. 02,<0. 05,<0. 01). Compared with the control group,the treatment group had greater advancement in LVEF,6 min walking distance,BNP and creatinine level at one month after operation ( F=6. 10,63. 60,51. 00,348. 00,P=0. 02,<0. 01,<0. 01,<0. 01) . Conclusion Levosimendan can effectively improve the heart function and renal function, improve the success rate of PCI in patients with ischemic heart failure and reduce the incidence of complications.
ABSTRACT
Objective Experimental study on effects of Yangxinshi tablets in the prevention and treatment of chronic is-chemic heart failure and acute myocardial ischemia reperfusion injury in order to provide a theoretical basis for its clinical appli-cation .Method Rat model of chronic ischemic heart failure and acute ischemia reperfusion mouse model of myocardial infarc-tion were constructed through coronary artery ligation .Those animals were randomized to sham operation group ,model group , positive drug group ,high Yangxinshi tablet dose group ,middle Yangxinshi tablet dose group ,low Yangxinshi tablet dose group .Rat electrocardiogram ,ultrasound ,ACE ,ACD ,TNF-a ,mouse myocardial infarction area ,CK ,LDH ,SOD and relat-ed factors were recorded during pre-dosing and post-dosing after modeling .Morphological changes were observed with cardiac pathological section .Results The biochemical indicators in model group were significantly different from sham operation group with statistical significance (P<0 .001) .Compared to the model group ,positive drug group and high Yangxinshi tablet dose group exhibited biochemical differences with statistical significance (P<0 .001 ,P<0 .01 ,P<0 .05) ,significant myocardial in-farction area reduction (P<0 .01 ,P<0 .05) ,improvement in myocardial cells and reduction in the cell infiltration .Conclusion Yangxinshi tablets have preventive and therapeutic effects on chronic ischemic heart failure and acute ischemia reperfusion in-jury .
ABSTRACT
@#The aim of this study was to develop a multi-target pharmacokinetic-pharmacodynamic(PK-PD)model for the evaluation of the protective effect of salvianolic acid A(Sal A)on ischemic heart failure based on a metabolic balance model. The rats were assigned to 3 groups: sham-operated group(saline), ischemic heart failure group(saline)and Sal A-treated group(Sal A, 1 mg/(kg ·d), ip). The concentrations of brain natriuretic peptide(BNP), angiotensin II(Ang II), malondialdehyde(MDA), asymmetric dimethylarginine(ADMA)and the activity of glutathione peroxidase(GSH-Px)in rat plasma were determined before and at 1, 2, 3, and 4 weeks after ligation in all the groups. A multi-target PK-PD model was developed based on the change rate of metabolic disruption parameter k and was eventually used to integrally evaluate the protective effect of Sal A on ischemic heart failure. Sal A showed improvement effects on multiple biomarkers and the correlation study demonstrated a good relationship between dynamic parameter k and left ventricular ejection fraction(LVEF). More importantly, the multi-target model well fitted the relationship between AUC and the change rate. The multi-target PK-PD model provides a novel method to integrally evaluate the protective effect of Sal A, which might offer a new strategy for the establishment of a PK-PD model that embodies the characteristics of traditional Chinese medicine.
ABSTRACT
Objective To compare effect and psychological state between ICU and conventional treatment in elderly patients with ischemic heart failure.Methods A total of 64 consecutives diagnosed as ischemic heart failure in the Second Center Hospital of Baoding from June 2013 to June 2014 were divided randomly into experiment and control group, each of 32 cases, after getting approval of our hospital's ethics committee and informed consent right of patients ,family members.The patients in experiment group were advised into ICU, and the patients in control group were into common ward, then compared the differences of cardiac functions,clinical effect and scale anxiety score (SAS), scale depression score (SDS).Results The left ventricular end diastolic diameter (LVEDd), ejection fraction (EF) and NYHA class in the two groups after treatment were both better than before, and the experiment group were significantly better than the control group (LVEDd: (56.7±4.1) mm vs.(59.2 ± 4.6) mm;EF : 0.49 ± 0.05 vs.0.42 ± 0.04;NYHAI degree: 23 vs 22;NYHA Ⅱ-Ⅲ degree: 11 vs 17;t =3.105,3.416;x2 =0.714,3.513;P＜0.05).The in-hosptical days and fees in experiment group were significantly less than the control group(t =3.846,3.913;P＜0.05).The treatment types in the two groups were no statistical difference (P ＞ 0.05).The death rate in-hosptical and follow-up in experiment group were both significantly lower than the control group(9.4％ vs.21.9％;12.5％ vs.28.1％;x2 =3.102,3.715;P＜0.05).The SAS, SDS scores in the two groups after treatment were both higher than before, and the control group were significantly higher than the treatment group(t =3.326,3.845;P＜0.05).Conclusion The serious condition of elderly patients with ischemic heart failure are better to ICU, which could greatly improve clinical effect and anxiety depression.
ABSTRACT
After myocardial infarction (MI), activation of the immune system and inflammatory mechanisms, among others, can lead to ventricular remodeling and heart failure (HF). The interaction between these systemic alterations and corresponding changes in the heart has not been extensively examined in the setting of chronic ischemia. The main purpose of this study was to investigate alterations in cardiac gene and systemic cytokine profile in mice with post-ischemic HF. Plasma was tested for IgM and IgG anti-heart reactive repertoire and inflammatory cytokines. Heart samples were assayed for gene expression by analyzing hybridization to AECOM 32k mouse microarrays. Ischemic HF significantly increased the levels of total serum IgM (by 5.2-fold) and total IgG (by 3.6-fold) associated with a relatively high content of anti-heart specificity. A comparable increase was observed in the levels of circulating pro-inflammatory cytokines such as IL-1â (3.8X) and TNF-á (6.0X). IFN-ã was also increased by 3.1-fold in the MI group. However, IL-4 and IL-10 were not significantly different between the MI and sham-operated groups. Chemokines such as MCP-1 and IL-8 were 1.4- and 13-fold increased, respectively, in the plasma of infarcted mice. We identified 2079 well annotated unigenes that were significantly regulated by post-ischemic HF. Complement activation and immune response were among the most up-regulated processes. Interestingly, 21 of the 101 quantified unigenes involved in the inflammatory response were significantly up-regulated and none were down-regulated. These data indicate that post-ischemic heart remodeling is accompanied by immune-mediated mechanisms that act both systemically and locally.
Subject(s)
Animals , Female , Male , Mice , Cytokines/blood , Heart Failure/immunology , Autoantibodies/blood , Disease Models, Animal , Echocardiography , Gene Expression Profiling , Heart Failure/blood , Heart Failure/etiology , Immunoglobulin G/blood , Immunoglobulin M/blood , Myocardial Ischemia/complications , Myocardial Ischemia/immunology , Reverse Transcriptase Polymerase Chain ReactionABSTRACT
Objective To evaluate the method of establishment of a minipig model of ischemic heart failure(HF) with acute myocardial infarction(AMI) by coronary balloon occlusion and coadministration of injecting of microthrombi and plastic microspheres.Methods A total of eighteen minipigs were selected.After coronary angiography,angioplasty balloons were placed in the mid-distal of left anterior descending(LAD).The balloon was inflated intermittently to occlude the LAD 3 times and then to occlude it continuously for 120 minutes.After the balloon was taken out,4F Judkins-type angiogrphic catheter was superelectively engaged in LAD and 3 mL intermixture of mierothrombi and plastic microspheres were injected at 10 minites interval until TIMI myocardial perfusion was grade<2 and left ventfieular end-diastolic pressure was maintained from 15 to 18 mmHg.Electrocardiogram(ECG),hemodynamic perameters,ultrasonic cardiogram,cTnI and CK-MB were measured.Myocardial infarction area was evaluated by histopathology.Results Fourteen days later,fifteen minipigs survived and fourteen satisfied the criteria(pulmonary capillary wedge pressure.PCWP>18 mmHg and eardio output (CO) decreased beyond 30% ). The changes of ECG, hemodynamic perameters, CKMB, cTnI and cardiac pathologic examination were in accordance with AMI. Conclusion A stable experimental method of establishment of minipig model of ischemic heart failure (HF) with acute myocardial infarction (AMI) by coronary balloon occlusion and coadministration of injecting of microthrombi and plastic mierospheres is succeded. This method has advantages such as closed chest, higher success rate and stability compared with the drug induced, taehycardia-pacing induced, coronary artery ligation induced or microsphere injection alone methods.
ABSTRACT
Se realizó una investigación descriptiva, longitudinal y prospectiva, con una muestra constituida por 120 pacientes, pertenecientes al área de salud Turcios Lima y atendidos en la Clínica Estomatológica "Guamá", del municipio Pinar del Río, durante el año 2008, con el objetivo de determinar la relación entre la enfermedad periodontal y la cardiopatía isquémica. Los pacientes fueron divididos en dos grupos etarios: grupo A(Control) integrado por 60 pacientes escogidos aleatoriamente que asistían a nuestra consulta y sin historia de infarto agudo del miocardio, y el grupo B (pacientes infartados) de 60 pacientes que fueron remitidos desde los consultorios médicos para ser incluidos en esta investigación. Al total se aplicó el índice de necesidad de tratamiento periodontal de la comunidad. Todos los pacientes infartados grupo B sufrieron periodontopatías, mientras que entre los no infartados solo la mitad padecieron de afecciones parodontales. Se utilizaron los métodos de la Estadísticos descriptiva y la comparación de frecuencias de Ji cuadrado al 95 % de certeza. El hábito de fumar, la edad mayor de 50 años, el sexo masculino y la mala higiene bucal se identificaron como factores comunes de riesgo para ambas enfermedades. Los estadios más avanzados de la enfermedad periodontal (bolsas de 6 mm o más), aumentaron su incidencia con la edad y fue más frecuente en los pacientes infartados, con mayor necesidad de cirugía periodontal. Todos los pacientes afectados tenían necesidad de adiestramiento en cepillado dental.
A descriptive, longitudinal and prospective research was conducted with a sample of 120 patients belonging to the primary care health area of "Turcios Lima" Outpatient Clinic attending to "Guama" Dentist's Clinic in Pinar del Rio municipality during 2008, and was aimed at determining the relation between periodontal diseases and ischemic heart failure. The patients were divided into two groups: A (control) comprised of 60 patients randomly chosen from those attended to the dentist office without medical history of acute myocardial infarction, and group B- (patients who suffered from infarction) 60 patients referred from the family medical office. The total of the sample was examined and the rate of need for periodontal treatment of the community was applied. Descriptive statistic methods were used, and Ji squared test for 95 % of certainty was used to compare frequencies. All patients of the group-B suffered from periodontopathies, meanwhile those belonging to group-A only the half of them suffered from parodontal affections. The smoking habit, over 50 years, male sex and poor oral hygiene were identified as common risk factors for both diseases. The most advanced stages for periodontal disease (bursas of 6mm or more) increased with age being more frequent in patients of group-B having a greater need of periodontal surgery. All the patients affected had to be trained in teeth brushing.
ABSTRACT
Introducción: El síndrome metabólico (SM) se presenta como un conjunto de desórdenes metabólicos y médicos. Cuatro de éstos (la obesidad, especialmente la obesidad central, la alteración del control de la glucosa en sangre, el alto nivel de lípidos en sangre y la hipertensión) se desarrollan a un mismo tiempo con mayor frecuencia de la que puede explicar la casualidad. Objetivo: Determinar la prevalencia de obesidad en gerontes con Síndrome Metabólico así como la asociación de la misma con algunos factores. Material y método: Se realizó un estudio observacional, descriptivo, transversal, en sujetos de 60 años o más que asistieron a dos consultorios del Policlínico "Turcios Lima" ciudad Pinar del Río mayo 2006 - diciembre 2007.Resultados: En el sexo femenino el 42.1 % eran obesas, y en el masculino el 36.4 %, con ligero incremento en el grupo de 60-64 años para ambos sexos, el 81.6 % de las mujeres tenía, la circunferencia abdominal elevada. La obesidad aparecía en el 42.3 %, con antecedentes patológicos personales y en el 34.2% sin antecedentes. Discusión: La obesidad se incrementa en el grupo de 60-64 años para ambos sexos, sin asociación con el sexo ni edades y tampoco con antecedentes patológicos aunque es mayor en individuos con antecedentes patológicos personales sin diferencia significativa. La circunferencia abdominal elevada fue más frecuente entre mujeres, se encontró asociación significativa entre circunferencia abdominal elevada y obesidad en ambos sexos.
The Metabolic Syndrome (MS) is shown as metabolic and clinical disorders. Four of them (obesity, mainly centrally located, blood glucose control alteration, high level of serum lipids and hypertension) are developed at once, more frequently than expected by chance. Objective: To determine the prevalence of obesity in elderly suffering form MS, so as its association to some other risk factors. Methods A cross-sectional, descriptive and observational study of case-controls was carried out on subjects aged 60 o older attending to two outpatient desk at the "Turcios Lima" Polyclinics in Pinar del Rio Municipality during the period May 2006- December 2007. Results Obesity was found in 42.1 % of women, and 36.4 % of men, slightly increased in the group of 60-64 y.o. for both sexes. 81.6 % of women showed abdominal circumference widened. Obesity appeared in 42.3 % of people having pathological personal antecedents, and in 34.2 % of people without them. Conclusions: Abdominal obesity is more frequently in women during elderly, and obesity and widened abdominal circumference were correlated.
ABSTRACT
BACKGROUND: Ischemic cardiomyopathy and dilated cardiomyopathy may be clinically indistinguishable and cardiac catheterization is often required to differentiate between them. And many nonivasive methods including myocardial Thallium scan have showed nonspecific results in differentiating between them. METHODS: We studied the change of echocardiographic ejection fraction after exercise in 8 patients with ischemic heart failure and 9 patients with dilated cardiomyopathy and have assessed the usefulness of this noninvasive technique in distinguishing between the two groups. RESULTS: All patients with ischemic cardiomyopathy displayed the significant decrease of ejection fraction at 5 minutes after exercise(p28.75+/-7.89%-->34.38+/-8.50%). Respectively, all patients with dilated cardiomyopathy showed the significant increment of ejection fraction at 5 minutes(p46.33+/-11.93%-->35.00+/-5.68%). CONCLUSION: Our results suggest that echocardiographic ejection fraction at post-exercise 5 minutes, will be the adjunctive method to differentiate between ischemic cardiomyopathy and dilated cardiomyopathy.